Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27926639)

Published in Obstet Gynecol on December 02, 2016

Authors

Brian T Bateman1, Elisabetta Patorno, Rishi J Desai, Ellen W Seely, Helen Mogun, Sara Z Dejene, Michael A Fischer, Alexander M Friedman, Sonia Hernandez-Diaz, Krista F Huybrechts

Author Affiliations

1: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine and the Division of Endocrinology, Diabetes and Metabolism, Brigham and Women's Hospital, Harvard Medical School, the Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, and the Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts; and the Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, New York.

Associated clinical trials:

Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 (REPLACECOVID) | NCT04338009

Articles cited by this

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA (2014) 34.12

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83

Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol (2013) 6.24

Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99

Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25

Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA (2015) 3.20

Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ (2011) 2.57

Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf (2012) 1.81

Statins and congenital malformations: cohort study. BMJ (2015) 1.75

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74

Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65

Validation of an obstetric comorbidity index in an external population. BJOG (2015) 1.42

Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med (2016) 1.33

Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol (1993) 1.32

Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf (2008) 1.21

Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf (2014) 1.19

Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One (2012) 1.13

Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol (1991) 1.09

Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension (2012) 1.04

Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ (2015) 1.00

Estimating the proportion of all observed birth defects occurring in pregnancies terminated by a second-trimester abortion. Epidemiology (2014) 0.96

ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology (1991) 0.94

Teratogenicity of angiotensin converting enzyme inhibitors or receptor blockers. J Obstet Gynaecol (2011) 0.93

Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol (2014) 0.89

The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension (2013) 0.84

Hypertension: ACE inhibitor use in pregnancy--setting the record straight. Nat Rev Cardiol (2011) 0.80

Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A Clin Mol Teratol (2012) 0.80

Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis. Pediatr Cardiol (2015) 0.78

Articles by these authors

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19

Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 5.91

Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99

Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med (2008) 4.63

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (2013) 3.88

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction. Epidemiology (2006) 3.71

Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol (2005) 3.37

The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98

The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int (2004) 2.88

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85

Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol (2014) 2.67

Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65

Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. Arch Dermatol (2006) 2.56

Patients' perceptions of generic medications. Health Aff (Millwood) (2009) 2.54

Dissecting the workforce and workplace for clinical endocrinology, and the work of endocrinologists early in their careers. J Clin Endocrinol Metab (2011) 2.47

Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther (2011) 2.24

Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13

Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology (2013) 2.06

Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg (2014) 2.04

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum (2006) 1.94

Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83

Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum (2013) 1.80

Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab (2007) 1.78

Trends and predictors of folic acid awareness and periconceptional use in pregnant women. Am J Obstet Gynecol (2005) 1.78

Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension (2005) 1.77

Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol (2011) 1.77

Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum (2006) 1.77

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74

Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause (2011) 1.72

Development of a comorbidity index for use in obstetric patients. Obstet Gynecol (2013) 1.65

Perioperative factors associated with prolonged mechanical ventilation after complex congenital heart surgery. Pediatr Crit Care Med (2011) 1.64

Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med (2007) 1.62

Patient, physician, and payment predictors of statin adherence. Med Care (2010) 1.59

At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59

The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol (2012) 1.58

Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58

Underuse of osteoporosis medications in elderly patients with fractures. Am J Med (2003) 1.57

Statins and the risk of lung, breast, and colorectal cancer in the elderly. Circulation (2006) 1.51

Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol (2012) 1.51

Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One (2011) 1.50

Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med (2007) 1.50

Effects of estradiol and the angiotensin II receptor blocker irbesartan on vascular function in postmenopausal women. Menopause (2008) 1.49

Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res (2006) 1.43

The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care (2010) 1.43

Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab (2008) 1.42

Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection. Obstet Gynecol (2020) 1.40

Physician perceptions about generic drugs. Ann Pharmacother (2011) 1.40

First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension (2010) 1.39

Medicaid's prior authorization program and access to atypical antipsychotic medications. Health Aff (Millwood) (2007) 1.38

Menopausal vasomotor symptoms and circulating hemostatic markers: causation or just association? Menopause (2011) 1.38

National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry (2013) 1.36

Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab (2005) 1.35

Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab (2004) 1.34

Cancer and the risk of suicide in older Americans. J Clin Oncol (2008) 1.33

Identifying postpartum intervention approaches to prevent type 2 diabetes in women with a history of gestational diabetes. BMC Pregnancy Childbirth (2011) 1.33

Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence. Am J Manag Care (2010) 1.32

The development, implementation, and assessment of an innovative faculty mentoring leadership program. Acad Med (2012) 1.28

Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol (2011) 1.28

Prescription drug insurance coverage and patient health outcomes: a systematic review. Am J Public Health (2015) 1.27

Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25

Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology (2014) 1.24

How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf (2004) 1.24

Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care (2007) 1.21

Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension (2010) 1.20

Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res (2011) 1.20

Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf (2014) 1.19

Increased sensitivity to angiotensin II is present postpartum in women with a history of hypertensive pregnancy. Hypertension (2010) 1.18

The consequences of requesting "dispense as written". Am J Med (2011) 1.16

Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf (2013) 1.15

Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care (2009) 1.15

25-Hydroxyvitamin D is associated with plasma renin activity and the pressor response to dietary sodium intake in Caucasians. J Renin Angiotensin Aldosterone Syst (2011) 1.13

Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending. Health Aff (Millwood) (2006) 1.13

Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One (2012) 1.13

Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum (2012) 1.11

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care (2003) 1.11

Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol (2009) 1.10

Academic women faculty: are they finding the mentoring they need? J Womens Health (Larchmt) (2012) 1.10

Targeting cardiovascular medication adherence interventions. J Am Pharm Assoc (2003) (2012) 1.10

The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol (2015) 1.09

The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab (2007) 1.09

Variations in the Use of Perioperative Multimodal Analgesic Therapy. Anesthesiology (2016) 1.08